17.05.2011 • News

Teva CEO Shlomo Yanai Says Always Looking for More Acquisitions

Teva CEO Shlomo Yanai
Teva CEO Shlomo Yanai

Teva Pharmaceutical Industries is always looking for acquisitions and will move on other potential targets when it finds a strategic fit, its top executive said on Monday.

"We are scrutinizing constantly the opportunities and in due time we will move for further acquisitions when we find them a ... strategic fit," Teva CEO Shlomo Yanai said at a briefing in Tokyo.

Teva said on Monday that it would acquire 57% of privately held Taiyo Pharmaceutical Industry for $460 million in cash and would make an offer to buy the remaining shares of Japan's third-largest generic pharmaceutical company.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.